Seattle Genetics (SGEN) Tops Q3 EPS by 11c

Seattle Genetics (NASDAQ: SGEN) reported Q3 EPS of ($0.13), $0.11 better than the analyst estimate of ($0.24). Revenue for the quarter came in at $75.8 million versus the consensus estimate of $66.9 million.

For earnings history and earnings-related data on Seattle Genetics (SGEN) click here.

You May Also Be Interested In

• Rivian reports record Q3 deliveries, beats estimates, shares rise
• DBS cuts Sea target as Shopee spending weighs on profit growth
• Piper Sandler on Virtu Financial (VIRT): 'The most overlooked name in our coverage'